A 26-year-old female recently diagnosed with stage III infiltrating ductal carcinoma of her left breast, was referred to our outpatient oncology clinic for initiation of chemotherapy. Her pretreatment workup was unremarkable, including a normal transthoracic echocardiogram (TTE) with an ejection fraction of 55%. She was referred to the vascular surgeon to establish intravenous access for treatment and on May 11, 2015 underwent central venous catheter (CVC) insertion in her right internal jugular vein. She received her first course of chemotherapy on May 12, which included carboplatin, docetaxel, pertuzumab and trastuzumab. She tolerated her first treatment well and received her second course of chemotherapy on June 11.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The American Journal of the Medical Sciences
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Catheter-related thrombosis in cancer patients: pathophysiology, diagnosis, and management.Hematol Oncol Clin North Am. 2005; 19: 183-202
- Right atrial thrombi are related to indwelling central venous catheter position: insights into time course and possible mechanism of formation.Am Heart J. 1998; 135: 457-462
Published online: January 18, 2016
☆The authors have no financial or conflicts of interest to disclose.
© 2016 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.